Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma Metastases

References

1. 1.↵
   2. Suh CH,
   3. Jung SC,
   4. Kim KW, et al

   . The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis. J Neurooncol 2016;129:363–71 doi:10.1007/s11060-016-2185-y pmid:27324495

   CrossRefPubMed
2. 2.↵
   2. Kaufmann TJ,
   3. Smits M,
   4. Boxerman J, et al

   . Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol 2020;22:757–72 doi:10.1093/neuonc/noaa030 pmid:32048719

   CrossRefPubMed
3. 3.↵
   2. Ginat DT,
   3. Meyers SP

   . Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics 2012;32:499–516 doi:10.1148/rg.322105761 pmid:22411945

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Bordia R,
   3. Zhong H,
   4. Lee J, et al

   . Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival. J Neurooncol 2017;131:341–48 doi:10.1007/s11060-016-2305-8 pmid:27822597

   CrossRefPubMed
5. 5.↵
   2. Lasocki A,
   3. McArthur GA

   . Correlation of MRI signal characteristics of intracranial melanoma metastases with BRAF mutation status. Melanoma Res 2022;32:373–78 doi:10.1097/CMR.0000000000000847 pmid:35979667

   CrossRefPubMed
6. 6.↵
   2. Byrne TN,
   3. Cascino TL,
   4. Posner JB

   . Brain metastasis from melanoma. J Neurooncol 1983;1:313–17 doi:10.1007/BF00165714 pmid:6678974

   CrossRefPubMed
7. 7.↵
   2. Ong BC,
   3. Stuckey SL

   . Susceptibility weighted imaging: a pictorial review. J Med Imaging Radiat Oncol 2010;54:435–49 doi:10.1111/j.1754-9485.2010.02208.x pmid:20958942

   CrossRefPubMed
8. 8.↵
   2. Hsu CC,
   3. Haacke EM,
   4. Heyn CC, et al

   . The T1 shine through effect on susceptibility weighted imaging: an under recognized phenomenon. Neuroradiology 2018;60:235–37 doi:10.1007/s00234-018-1977-5 pmid:29330657

   CrossRefPubMed
9. 9.↵
   2. Lasocki A,
   3. Caspersz L,
   4. McArthur GA

   . Prospective comparison of volumetric post-contrast T1-sampling perfection with application optimized contrasts by using different flip angle evolutions and magnetization-prepared rapid acquisition with gradient echo in patients with metastatic melanoma. Neuroradiol J 2023;36:169–75 doi:10.1177/19714009221114440 pmid:35815337

   CrossRefPubMed
10. 10.↵
    2. Goncalves Filho AL,
    3. Longo MG,
    4. Conklin J, et al

    . MRI highly accelerated wave-CAIPI T1-SPACE versus standard T1-SPACE to detect brain gadolinium-enhancing lesions at 3T. J Neuroimaging 2021;31:893–901 doi:10.1111/jon.12893 pmid:34081374

    CrossRefPubMed
11. 11.↵
    2. Kammer NN,
    3. Coppenrath E,
    4. Treitl KM, et al

    . Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours. Eur Radiol 2016;26:1818–25 doi:10.1007/s00330-015-3975-x pmid:26334511

    CrossRefPubMed
12. 12.↵
    2. Nagao E,
    3. Yoshiura T,
    4. Hiwatashi A, et al

    . 3D turbo spin-echo sequence with motion-sensitized driven-equilibrium preparation for detection of brain metastases on 3T MR imaging. AJNR Am J Neuroradiol 2011;32:664–70 doi:10.3174/ajnr.A2343 pmid:21292797

    Abstract/FREE Full Text
13. 13.↵
    2. Lasocki A,
    3. Khoo C,
    4. Lau PK, et al

    . High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges. Neuro-oncology 2020;22:423–32 doi:10.1093/neuonc/noz171 pmid:31498868

    CrossRefPubMed
14. 14.↵
    2. Smirniotopoulos JG,
    3. Murphy FM,
    4. Rushing EJ, et al

    . Patterns of contrast enhancement in the brain and meninges. Radiographics 2007;27:525–51 doi:10.1148/rg.272065155 pmid:17374867

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Altun E,
    3. Semelka RC,
    4. Dale BM, et al

    . Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI. J Magn Reson Imaging 2008;27:1146–54 doi:10.1002/jmri.21346 pmid:18425826

    CrossRefPubMed